Document Detail


Detection of (18)Fluoride Sodium Accumulation by Positron Emission Tomography in Calcified Stenotic Aortic Valves.
MedLine Citation:
PMID:  22264594     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Aortic valve stenosis progression rate is highly variable among patients and to date remains unpredictable. Evaluation of osteoblastic activity inside aortic valves may help identify patients with fast aortic stenosis progression rates and worse prognoses. Fluoride-18 sodium (FNa) is a clinically approved positron emission tomographic (PET) radiotracer with high and rapid bone uptake. The aim of this study was to test whether FNa accumulates in degenerative aortic valves and can be detected with PET imaging. Five patients with severe aortic stenosis and 10 patients free of aortic valvular calcium on computed tomography underwent PET imaging 40 minutes after the injection of 4 MBq/kg of FNa for oncologic or rheumatologic purposes. Maximal standard uptake values (SUVs) were measured retrospectively in aortic valves using PET imaging. Tissue-to-background ratios were calculated for each patient by dividing the maximal SUV measured in aortic valves by the mean SUV of blood. In patients with severe aortic stenosis, an intense accumulation of FNa was detected in aortic valve region on PET imaging, whereas only low activity was found in patients free of valvular calcification (median maximal SUV 2.6 g/ml/kg [interquartile range (IQR) 2.3 to 3.6] vs 2.0 g/ml/kg [IQR 1.7 to 2.2] and median tissue-to-background ratio 2.2 [IQR 2.0 to 2.7] vs 1.5 [IQR 1.5 to 1.7], respectively, p = 0.008 for both). Intraobserver variability for maximal SUV and tissue-to-background ratio in aortic valves was measured at 0.99 and interobserver variability at 0.98 and 0.97, respectively. In conclusion, in this pilot study, FNa accumulated in patients with severe aortic stenosis and could be quantified on PET imaging with good reproducibility. FNa PET imaging represents a promising imaging modality to evaluate osteoblastic activity inside calcified aortic valves.
Authors:
Fabien Hyafil; David Messika-Zeitoun; Samuel Burg; François Rouzet; Khadija Benali; Bernard Iung; Alec Vahanian; Dominique Le Guludec
Related Documents :
24378974 - The effect of recombinant human soluble thrombomodulin on disseminated intravascular co...
996714 - Revascularization of the peroneal artery.
22115244 - Successful transcatheter aortic valve implantation through ascending aorta and total re...
17149714 - Outcome following bypass, and proximal and distal ligation of popliteal aneurysms.
23453864 - Type i spinal arteriovenous fistulae exception: a case for reclassification.
6354334 - The septum orbitale in ptosis surgery.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-18
Journal Detail:
Title:  The American journal of cardiology     Volume:  -     ISSN:  1879-1913     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
Affiliation:
Department of Nuclear Medicine Bichat, CHU Bichat, Assistance Publique - Hôpitaux de Paris, University Paris Diderot, Sorbonne Paris Cité, Paris, France; INSERM 698 Cardiovascular Bioengineering, and University Paris Diderot-Paris 7, University Paris Diderot, Sorbonne Paris Cité, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Outcomes of nonstenting percutaneous coronary intervention in patients with rheumatoid arthritis.
Next Document:  Myocardial Perfusion Magnetic Resonance Imaging Using Sliding-Window Conjugate-Gradient Highly Const...